Search

Your search keyword '"Zietemann, Vera"' showing total 4 results
Start Over Author "Zietemann, Vera" Topic small vessel disease
4 results on '"Zietemann, Vera"'

1. STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease

Author

Sachdev, Perminder S, Lo, Jessica W, Bae, Hee-Joon, Linden, Thomas, Blomstrand, Christian, Fagerberg, Björn, Skoog, Ingmar, Godefroy, Olivier, Barbay, Mélanie, Roussel, Martine, Lee, Byung-Chul, Yu, Kyung-Ho, Lim, Jae-Sung, Wardlaw, Joanna, Makin, Stephen J, Doubal, Fergus N, Chappell, Francesca M, Srikanth, Velandai K, Thrift, Amanda G, Donnan, Geoffrey A, Kandiah, Nagaendran, Chander, Russell J, Lin, Xuling, Brodtmann, Amy, Cordonnier, Charlotte, Moulin, Solene, Rossi, Costanza, Sabayan, Behnam, Stott, David J, Jukema, J Wouter, Melkas, Susanna, Jokinen, Hanna, Erkinjuntti, Timo, Mok, Vincent Ct, Werden, Emilio, Wong, Adrian, Lam, Bonnie Yk, Leys, Didier, Hénon, Hilde, Bombois, Stéphanie, Sachdev, Perminder, Cumming, Toby, Köhler, Sebastian, Verhey, Frans R J, Dong, Yan-Hong, Tan, Hui Hui, Chen, Christopher, Crawford, John D, Xin, Xu, Kalaria, Raj N, Allan, Louise M, Akinyemi, Rufus O, Ogunniyi, Adesola, Klimkowicz-Mrowiec, Aleksandra, Dichgans, Martin, Wollenweber, Frank A, Zietemann, Vera, Hoffmann, Michael, Mellon, Lisa, Desmond, David W, Hickey, Anne, Williams, David, Mok, Vincent C T, Bordet, Régis, Lam, Bonnie Y K, Lipnicki, Darren M, Kochan, Nicole A, STROKOG, Mendyk, Anne-Marie, Gelé, Patrick, Deplanque, Dominique, Verhey, Frans Rj, Xu, Jing, Akinyemi, Rufus, Kalariai, Raj N, Metacohorts Consortium, Department of Chemistry, Indiana University, Indiana University [Bloomington], Indiana University System-Indiana University System, School of Civil Engineering, The University of Queensland, School of Civil Engineering, Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 (TCDV), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille, Droit et Santé-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Lille Neurosciences & Cognition - U 1172 (LilNCog), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], McGill University = Université McGill [Montréal, Canada], University of Ibadan, Uniwersytet Jagielloński w Krakowie = Jagiellonian University (UJ), Department of Computer Science [ETH Zürich] (D-INFK), Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology [Zürich] (ETH Zürich), Institute of Neuroscience and Physiology [Göteborg], Service de neurologie [Amiens], CHU Amiens-Picardie, Laboratoire de Neurosciences Fonctionnelles et Pathologies - UR UPJV 4559 (LNFP), Université de Picardie Jules Verne (UPJV), University of Edinburgh, Harvard Medical School [Boston] (HMS), Interuniversity Cardiology Institute Netherlands, Helsinki University Central Hospital, Helsingin yliopisto = Helsingfors universitet = University of Helsinki, HUCH, Neurologian yksikkö, Clinicum, Department of Neurosciences, University of Helsinki, and HUS Neurocenter

Subjects
Gerontology, endocrine system, medicine.medical_specialty, [SDV]Life Sciences [q-bio], education, International consortium, 030204 cardiovascular system & hematology, Post-stroke dementia, Special Section: Vascular Contributions to Alzheimer's Disease, Vascular dementia, 3124 Neurology and psychiatry, 03 medical and health sciences, 0302 clinical medicine, Epidemiology, medicine, ddc:610, Stroke, Data harmonization, Post stroke dementia, 3112 Neurosciences, Cognition, medicine.disease, 3. Good health, Small vessel disease, Psychiatry and Mental health, Vascular cognitive disorder, Cohort studies, Neurology (clinical), Psychology, Neurocognitive, 030217 neurology & neurosurgery, Cohort study
Abstract

Introduction: \ud \ud The Stroke and Cognition consortium (STROKOG) aims to facilitate a better understanding of the determinants of vascular contributions to cognitive disorders and help improve the diagnosis and treatment of vascular cognitive disorders (VCD).\ud \ud Methods: \ud \ud Longitudinal studies with ≥75 participants who had suffered or were at risk of stroke or TIA and which evaluated cognitive function were invited to join STROKOG. The consortium will facilitate projects investigating rates and patterns of cognitive decline, risk factors for VCD, and biomarkers of vascular dementia.\ud \ud Results: \ud \ud Currently, STROKOG includes 25 (21 published) studies, with 12,092 participants from five continents. The duration of follow-up ranges from 3 months to 21 years.\ud \ud Discussion: \ud \ud Although data harmonization will be a key challenge, STROKOG is in a unique position to reuse and combine international cohort data and fully explore patient level characteristics and outcomes. STROKOG could potentially transform our understanding of VCD and have a worldwide impact on promoting better vascular cognitive outcomes.

Published
2017

2. METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration : An initiative of the Joint Programme for Neurodegenerative Disease Research

Author

Dichgans, Martin, Wardlaw, Joanna, Smith, Eric, Zietemann, Vera, Seshadri, Sudha, Sachdev, Perminder, Biessels, Geert Jan, Fazekas, Franz, Benavente, Oscar, Pantoni, Leonardo, Leeuw, Frank-Erik De, Norrving, Bo, Matthews, Paul, Chen, Christopher, Mok, Vincent, Düring, Marco, Whiteley, Will, Shuler, Kirsten, Alonso, Alvaro, Black, Sandra E., Brayne, Carol, Chabriat, Hugues, Cordonnier, Charlotte, Doubal, Fergus, Duzel, Emrah, Ewers, Michael, Frayne, Richard, Hachinski, Vladimir, Ikram, Mohammad Arfan, Jessen, Frank, Jouvent, Eric, Linn, Jennifer, O'Brien, John, Oostenbrugge, Robert van, Malik, Rainer, Mazoyer, Bernard, Schmidt, Reinhold, Sposato, Luciano A., Stephan, Blossom, Swartz, Richard H., Vernooij, Meike, Viswanathan, Anand, Werring, David, Abe, Koji, Allan, Louise, Arba, Francesco, Diener, H.-C., Davis, S., Hankey, G., Lees, K.R., Ovbiagele, B., Weir, C., Bae, Hee-Joon, Bath, Philip MW., Bordet, Regis, Breteler, Monique, Choi, Seong, Deary, Ian, DeCarli, Charles, Ebmeier, Klaus, Feng, Lei, Greenberg, Steven M., Ihara, Masafumi, Kalaria, Rajesh, Kim, SanYun, Lim, Jae-Sung, Lindley, Richard I., Mead, Gillian, Murray, Alison, Quinn, Terry, Ritchie, Craig, Sacco, Ralph, Salman, Rustam Al-Shahi, Sprigg, Nikola, Sudlow, Cathie, Thomas, Alan, Boxtel, Martin van, Grond, Jeroen van der, Lugt, Aad van der, Yang, Yuan-Han, Metacohorts Consortium, [GIN] Grenoble Institut des Neurosciences (GIN), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])

Subjects
Epidemiology, [SCCO.NEUR]Cognitive science/Neuroscience, Health Policy, Clinical Neurology, Neurodegeneration, Cohorts, Survey, Small vessel disease, Cellular and Molecular Neuroscience, Psychiatry and Mental health, Developmental Neuroscience, Journal Article, Dementia, Neurodegeneration, Geriatrics and Gerontology, Survey, Cerebrovascular disease, Cohorts
Abstract

Dementia is a global problem and major target for health care providers. Although up to 45% of cases are primarily or partly due to cerebrovascular disease, little is known of these mechanisms or treatments because most dementia research still focuses on pure Alzheimer's disease. An improved understanding of the vascular contributions to neurodegeneration and dementia, particularly by small vessel disease, is hampered by imprecise data, including the incidence and prevalence of symptomatic and clinically “silent” cerebrovascular disease, long-term outcomes (cognitive, stroke, or functional), and risk factors. New large collaborative studies with long follow-up are expensive and time consuming, yet substantial data to advance the field are available. In an initiative funded by the Joint Programme for Neurodegenerative Disease Research, 55 international experts surveyed and assessed available data, starting with European cohorts, to promote data sharing to advance understanding of how vascular disease affects brain structure and function, optimize methods for cerebrovascular disease in neurodegeneration research, and focus future research on gaps in knowledge. Here, we summarize the results and recommendations from this initiative. We identified data from over 90 studies, including over 660,000 participants, many being additional to neurodegeneration data initiatives. The enthusiastic response means that cohorts from North America, Australasia, and the Asia Pacific Region are included, creating a truly global, collaborative, data sharing platform, linked to major national dementia initiatives. Furthermore, the revised World Health Organization International Classification of Diseases version 11 should facilitate recognition of vascular-related brain damage by creating one category for all cerebrovascular disease presentations and thus accelerate identification of targets for dementia prevention.

Published
2016

3. METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research

Author

Dichgans, Martin, Wardlaw, Joanna, De Leeuw, Frank-Erik, Norrving, Bo, Matthews, Paul, Chen, Christopher, Mok, Vincent, Düring, Marco, Whiteley, Will, Shuler, Kirsten, Alonso, Alvaro, Black, Sandra E, Smith, Eric, Brayne, Carol, Chabriat, Hugues, Cordonnier, Charlotte, Doubal, Fergus, Duzel, Emrah, Ewers, Michael, Frayne, Richard, Hachinski, Vladimir, Ikram, Mohammad Arfan, Jessen, Frank, Zietemann, Vera, Jouvent, Eric, Linn, Jennifer, O'Brien, John, van Oostenbrugge, Robert, Malik, Rainer, Mazoyer, Bernard, Schmidt, Reinhold, Sposato, Luciano A, Stephan, Blossom, Swartz, Richard H, Seshadri, Sudha, Vernooij, Meike, Viswanathan, Anand, Werring, David, Abe, Koji, Allan, Louise, Arba, Francesco, Bae, Hee-Joon, Bath, Philip Mw, Bordet, Regis, Breteler, Monique, Sachdev, Perminder, Choi, Seong, Deary, Ian, DeCarli, Charles, Ebmeier, Klaus, Feng, Lei, Greenberg, Steven M, Ihara, Masafumi, Kalaria, Rajesh, Kim, SanYun, Lim, Jae-Sung, Biessels, Geert Jan, Lindley, Richard I, Mead, Gillian, Murray, Alison, Quinn, Terry, Ritchie, Craig, Sacco, Ralph, Al-Shahi Salman, Rustam, Sprigg, Nikola, Sudlow, Cathie, Thomas, Alan, Fazekas, Franz, van Boxtel, Martin, van der Grond, Jeroen, van der Lugt, Aad, Yang, Yuan-Han, Consortium, METACOHORTS, Benavente, Oscar, and Pantoni, Leonardo

Subjects
Male, Dementia, Vascular, Incidence, Neurodegenerative Diseases, Featured Article, Neurodegeneration, Cohorts, Survey, Small vessel disease, complications [Cerebrovascular Disorders], etiology [Neurodegenerative Diseases], Cohort Studies, Cerebrovascular Disorders, epidemiology [Cerebrovascular Disorders], Risk Factors, Surveys and Questionnaires, Prevalence, Humans, Dementia, Cognitive Dysfunction, Female, ddc:610, Cerebrovascular disease, Aged
Abstract

Dementia is a global problem and major target for health care providers. Although up to 45% of cases are primarily or partly due to cerebrovascular disease, little is known of these mechanisms or treatments because most dementia research still focuses on pure Alzheimer's disease. An improved understanding of the vascular contributions to neurodegeneration and dementia, particularly by small vessel disease, is hampered by imprecise data, including the incidence and prevalence of symptomatic and clinically "silent" cerebrovascular disease, long-term outcomes (cognitive, stroke, or functional), and risk factors. New large collaborative studies with long follow-up are expensive and time consuming, yet substantial data to advance the field are available. In an initiative funded by the Joint Programme for Neurodegenerative Disease Research, 55 international experts surveyed and assessed available data, starting with European cohorts, to promote data sharing to advance understanding of how vascular disease affects brain structure and function, optimize methods for cerebrovascular disease in neurodegeneration research, and focus future research on gaps in knowledge. Here, we summarize the results and recommendations from this initiative. We identified data from over 90 studies, including over 660,000 participants, many being additional to neurodegeneration data initiatives. The enthusiastic response means that cohorts from North America, Australasia, and the Asia Pacific Region are included, creating a truly global, collaborative, data sharing platform, linked to major national dementia initiatives. Furthermore, the revised World Health Organization International Classification of Diseases version 11 should facilitate recognition of vascular-related brain damage by creating one category for all cerebrovascular disease presentations and thus accelerate identification of targets for dementia prevention.

Published
2016

4. METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: an initiative of the Joint Programme for Neurodegenerative Disease Research

Author

Dichgans, Martin, Wardlaw, Joanna, Smith, Eric, Zietemann, Vera, Seshadri, Sudha, Sachdev, Perminder, Biessels, Geert Jan, Fazekas, Franz, Benavente, Oscar, Pantoni, Leonardo, De Leeuw, Frank-Erik, Norrving, Bo, Matthews, Paul, Chen, Christopher, Mok, Vincent, Whiteley, Will, Shuler, Kirsten, Alonso, Alvaro, Black, Sandra E., Brayne, Carol, Chabriat, Hugues, Cordonnier, Charlotte, Doubal, Fergus, Duzel, Emrah, Ewers, Michael, Frayne, Richard, Hachinski, Vladimir, Ikram, Mohammad Arfan, Jessen, Frank, Jouvent, Eric, Linn, Jennifer, O'Brien, John, van Oostenbrugge, Robert, Malik, Rainer, Mazoyer, Bernard, Schmidt, Reinhold, Sposato, Luciano A., Stephan, Blossom, Swartz, Richard H., Vernooij, Meike, Viswanathan, Anand, Werring, David, Abe, Koji, Allan, Louise, Arba, Francesco, Diener, H.-C., Davis, S., Hankey, G., Lees, K.R., Ovbiagele, B., Weir, C., Bae, Hee-Joon, Bath, Philip M.W., Bordet, Regis, Breteler, Monique, Choi, Seong, Deary, Ian, DeCarli, Charles, Ebmeier, Klaus, Feng, Lei, Greenberg, Steven M., Ihara, Masafumi, Kalaria, Rajesh, Kim, SanYun, Lim, Jae-Sung, Lindley, Richard I., Mead, Gillian, Murray, Alison, Quinn, Terry, Ritchie, Craig, Sacco, Ralph, Al-Shahi Salman, Rustam, Sprigg, Nikola, Sudlow, Cathie, Thomas, Alan, van Boxtel, Martin, van der Grond, Jeroen, van der Lugt, Aad, and Yang, Yuan-Han

Subjects
Dementia, Cerebrovascular disease, Neurodegeneration, Cohorts, Survey, Small vessel disease
Abstract

Dementia is a global problem and major target for health care providers. Although up to 45% of cases are primarily or partly due to cerebrovascular disease, little is known of these mechanisms or treatments because most dementia research still focuses on pure Alzheimer's disease. An improved understanding of the vascular contributions to neurodegeneration and dementia, particularly by small vessel disease, is hampered by imprecise data, including the incidence and prevalence of symptomatic and clinically “silent” cerebrovascular disease, long-term outcomes (cognitive, stroke, or functional), and risk factors. New large collaborative studies with long follow-up are expensive and time consuming, yet substantial data to advance the field are available. In an initiative funded by the Joint Programme for Neurodegenerative Disease Research, 55 international experts surveyed and assessed available data, starting with European cohorts, to promote data sharing to advance understanding of how vascular disease affects brain structure and function, optimize methods for cerebrovascular disease in neurodegeneration research, and focus future research on gaps in knowledge. Here, we summarize the results and recommendations from this initiative. We identified data from over 90 studies, including over 660,000 participants, many being additional to neurodegeneration data initiatives. The enthusiastic response means that cohorts from North America, Australasia, and the Asia Pacific Region are included, creating a truly global, collaborative, data sharing platform, linked to major national dementia initiatives. Furthermore, the revised World Health Organization International Classification of Diseases version 11 should facilitate recognition of vascular-related brain damage by creating one category for all cerebrovascular disease presentations and thus accelerate identification of targets for dementia prevention.

Catalog

Books, media, physical & digital resources
See catalog results